It is difficult to determine the pathoanatomical correlates of dystonia because of its complex pathophysiology, and most cases with secondary dystonia are associated with basal ganglia lesions. Moreover, it is a challenging issue that patients with abnormal postures accompanied by other neurological findings in the affected body part (e.g., sensory loss) can be diagnosed with true dystonia or pseudodystonia. Here, we report a case of abnormal postures with loss of proprioception in the left extremities after right dorsal pontine hemorrhage.
Citations
Citations to this article as recorded by
Rehabilitation of hemidystonia as a result of right pontine hemorrhagic stroke Melanie Aing, Craig DiTommaso The Journal of the International Society of Physical and Rehabilitation Medicine.2023; 6(4): 116. CrossRef
Hemidystonia after Pontine Hemorrhage Successfully Treated with Pharmacotherapy and Intensive Rehabilitation: a Case Report Gyu Seong Kim, Yeon Gyu Jeong, Yoon Jeong Jeong, Seo Yeon Yoon Brain & Neurorehabilitation.2021;[Epub] CrossRef
Martina Bocchetta, Juan Eugenio Iglesias, Viorica Chelban, Edwin Jabbari, Ruth Lamb, Lucy L. Russell, Caroline V. Greaves, Mollie Neason, David M. Cash, David L. Thomas, Jason D. Warren, John Woodside, Henry Houlden, Huw R. Morris, Jonathan D. Rohrer
J Mov Disord. 2020;13(1):39-46. Published online September 26, 2019
Objective Brainstem segmentation has been useful in identifying potential imaging biomarkers for diagnosis and progression in atypical parkinsonian syndromes (APS). However, the majority of work has been performed using manual segmentation, which is time consuming for large cohorts.
Methods We investigated brainstem involvement in APS using an automated method. We measured the volume of the medulla, pons, superior cerebellar peduncle (SCP) and midbrain from T1-weighted MRIs in 67 patients and 42 controls. Diagnoses were corticobasal syndrome (CBS, n = 14), multiple system atrophy (MSA, n = 16: 8 with parkinsonian syndrome, MSA-P; 8 with cerebellar syndrome, MSA-C), progressive supranuclear palsy with a Richardson’s syndrome (PSP-RS, n = 12), variant PSP (n = 18), and APS not otherwise specified (APS-NOS, n = 7).
Results All brainstem regions were smaller in MSA-C (19–42% volume difference, p < 0.0005) and in both PSP groups (18–33%, p < 0.0005) than in controls. MSA-P showed lower volumes in all regions except the SCP (15–26%, p < 0.0005). The most affected region in MSA-C and MSA-P was the pons (42% and 26%, respectively), while the most affected regions in both the PSP-RS and variant PSP groups were the SCP (33% and 23%, respectively) and midbrain (26% and 24%, respectively). The brainstem was less affected in CBS, but nonetheless, the pons (14%, p < 0.0005), midbrain (14%, p < 0.0005) and medulla (10%, p = 0.001) were significantly smaller in CBS than in controls. The brainstem was unaffected in APS-NOS.
Conclusion Automated methods can accurately quantify the involvement of brainstem structures in APS. This will be important in future trials with large patient numbers where manual segmentation is unfeasible.
Citations
Citations to this article as recorded by
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study Agnès Pérez-Millan, Sergi Borrego-Écija, John C. van Swieten, Lize Jiskoot, Fermin Moreno, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Journal of Neurology.2023; 270(3): 1573. CrossRef
Comparative validation of AI and non-AI methods in MRI volumetry to diagnose Parkinsonian syndromes Joomee Song, Juyoung Hahm, Jisoo Lee, Chae Yeon Lim, Myung Jin Chung, Jinyoung Youn, Jin Whan Cho, Jong Hyeon Ahn, Kyungsu Kim Scientific Reports.2023;[Epub] CrossRef
Identification of the pathogenesis features of various phenotypes of multiple sclerosis based on the study of the morphological functional connectivity of subcortical gray matter structures A. G. Trufanov, A. Y. Polushin, E. A. Gorbunova, M. V. Lukin Russian Journal for Personalized Medicine.2023; 3(1): 27. CrossRef
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort Martina Bocchetta, Emily G Todd, Arabella Bouzigues, David M Cash, Jennifer M Nicholas, Rhian S Convery, Lucy L Russell, David L Thomas, Ian B Malone, Juan Eugenio Iglesias, John C van Swieten, Lize C Jiskoot, Harro Seelaar, Barbara Borroni, Daniela Galim Brain Communications.2023;[Epub] CrossRef
Quantitative MRI protocol and decision model for a ‘one stop shop’ early-stage Parkinsonism diagnosis: Study design Samy Abo Seada, Anke W. van der Eerden, Agnita J.W. Boon, Juan A. Hernandez-Tamames NeuroImage: Clinical.2023; 39: 103506. CrossRef
Neuroimaging correlates of brain injury in Wilson’s disease: a multimodal, whole-brain MRI study Samuel Shribman, Martina Bocchetta, Carole H Sudre, Julio Acosta-Cabronero, Maggie Burrows, Paul Cook, David L Thomas, Godfrey T Gillett, Emmanuel A Tsochatzis, Oliver Bandmann, Jonathan D Rohrer, Thomas T Warner Brain.2022; 145(1): 263. CrossRef
Nuclear imaging in Parkinson's disease: The past, the present, and the future Haim Golan, Olga Volkov, Eli Shalom Journal of the Neurological Sciences.2022; 436: 120220. CrossRef
Criteria-unfulfilled multiple system atrophy at an initial stage exhibits laterality of middle cerebellar peduncles Minori Furuta, Masayuki Sato, Setsuki Tsukagoshi, Yoshito Tsushima, Yoshio Ikeda Journal of the Neurological Sciences.2022; 438: 120281. CrossRef
A data-driven model of brain volume changes in progressive supranuclear palsy W. J. Scotton, M. Bocchetta, E. Todd, D. M. Cash, N. Oxtoby, L. VandeVrede, H. Heuer, D. C. Alexander, J. B. Rowe, H. R. Morris, A. Boxer, J. D. Rohrer, P. A. Wijeratne Brain Communications.2022;[Epub] CrossRef
Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease Samuel Shribman, Maggie Burrows, Rhian Convery, Martina Bocchetta, Carole H. Sudre, Julio Acosta‐Cabronero, David L. Thomas, Godfrey T. Gillett, Emmanuel A. Tsochatzis, Oliver Bandmann, Jonathan D. Rohrer, Thomas T. Warner Movement Disorders.2022; 37(8): 1728. CrossRef
Corticobasal syndrome and Parkinson’s disease at the beginning: asymmetrical patterns of MRI and Blink Reflex for early diagnosis Giulia Donzuso, Giorgia Sciacca, Antonina Luca, Calogero E. Cicero, Giovanni Mostile, Alessandra Nicoletti, Mario Zappia Journal of Neural Transmission.2022; 129(12): 1427. CrossRef
Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy Ji-Hyun Choi, Heejung Kim, Jung Hwan Shin, Jee-Young Lee, Han-Joon Kim, Jong-Min Kim, Beomseok Jeon Journal of Neurology.2021; 268(3): 967. CrossRef
Artificial intelligence applied to neuroimaging data in Parkinsonian syndromes: Actuality and expectations Annalisa Vitale, Rossella Villa, Lorenzo Ugga, Valeria Romeo, Arnaldo Stanzione, Renato Cuocolo Mathematical Biosciences and Engineering.2021; 18(2): 1753. CrossRef
Differential early subcortical involvement in genetic FTD within the GENFI cohort Martina Bocchetta, Emily G. Todd, Georgia Peakman, David M. Cash, Rhian S. Convery, Lucy L. Russell, David L. Thomas, Juan Eugenio Iglesias, John C. van Swieten, Lize C. Jiskoot, Harro Seelaar, Barbara Borroni, Daniela Galimberti, Raquel Sanchez-Valle, Ro NeuroImage: Clinical.2021; 30: 102646. CrossRef
Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes Germain Arribarat, Patrice Péran Current Opinion in Neurology.2020; 33(2): 222. CrossRef
Objective Recent reports of hearing impairment in Parkinson’s disease (PD) have suggested that auditory dysfunction could be a non-motor manifestation of PD. These reports were based on observations of elderly patients for whom presbycusis may, to some extent, have contributed to hearing dysfunction. Therefore, we aimed to explore the auditory functions in younger patients with PD. Methods We conducted a case-control study in a relatively younger (< 55 years of age at study time) population of PD patients and healthy volunteers to test whether auditory dysfunction is a significant non-motor dysfunction in PD. Pure tone audiometry (PTA) and brainstem evoked response audiometry (BERA) were performed in all participants. Results None of the patients or controls reported hearing deficits. Fifty-one patients with PD and 50 healthy volunteers who were age- and gender-matched to the patients participated. PTA-detected hearing impairment was found in 64.7% of patients and 28% of controls (p < 0.001) for both low-mid and/or high frequencies. Hearing impairment was more frequent in the younger subgroups of patients than age-matched controls, while the frequency of hearing impairment was similar in older groups of subjects. BERA was not different between patients and controls. Conclusion Asymptomatic auditory dysfunction is a common non-motor manifestation of early-onset PD and more frequent in younger patients, indicating that it may be independent of aging. The mechanism underlying this dysfunction appears to be peripheral, although a central dysfunction cannot be ruled out based on the findings of this study.
Citations
Citations to this article as recorded by
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum Elena Garasto, Alessandro Stefani, Mariangela Pierantozzi, Matteo Conti, Arturo Moleti, Renata Sisto, Andrea Viziano, Claudio Liguori, Tommaso Schirinzi, Nicola Biagio Mercuri, Rocco Cerroni Neurological Sciences.2024; 45(9): 4299. CrossRef
Relationship of Hearing Loss to Parkinson’s Disease, Dementia, and APOE Genotype in Adults Chih-Hung Cha, Tsu-Kung Lin, Ching-Nung Wu, Chao-Hui Yang, Yi-Wen Huang, Chung-Feng Hwang Medicina.2024; 60(5): 703. CrossRef
Disturbance in the protein landscape of cochlear perilymph in an Alzheimer’s disease mouse model Masatoshi Fukuda, Hiroki Okanishi, Daisuke Ino, Kazuya Ono, Satoru Kawamura, Eri Wakai, Tsuyoshi Miyoshi, Takashi Sato, Yumi Ohta, Takashi Saito, Takaomi C. Saido, Hidenori Inohara, Yoshikatsu Kanai, Hiroshi Hibino, Abdelwahab Omri PLOS ONE.2024; 19(5): e0303375. CrossRef
Peripheral hearing in Parkinson’s disease: a systematic review Mariana S. Leme, Seisse G. G. Sanches, Renata M. M. Carvallo International Journal of Audiology.2023; 62(9): 805. CrossRef
(Zu-)Hören mit alterndem Gehirn – eine kognitive
Herausforderung Wilma Großmann Laryngo-Rhino-Otologie.2023; 102(S 01): S12. CrossRef
Is Hearing Loss a Risk Factor for Idiopathic Parkinson’s Disease? An English Longitudinal Study of Ageing Analysis Megan Rose Readman, Fang Wan, Ian Fairman, Sally A. Linkenauger, Trevor J. Crawford, Christopher J. Plack Brain Sciences.2023; 13(8): 1196. CrossRef
Hearing Loss and Disorders: The Repercussions of Climate Change Sue Sherratt American Journal of Audiology.2023; 32(4): 793. CrossRef
Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease Elena Garasto, Alessandro Stefani, Mariangela Pierantozzi, Rocco Cerroni, Matteo Conti, Simone Maranesi, Nicola B Mercuri, Agostino Chiaravalloti, Orazio Schillaci, Andrea Viziano, Arturo Moleti, Renata Sisto Brain Communications.2023;[Epub] CrossRef
Identifying Parkinson Risk Markers in Primary Care—Old Associations and New Insights Bhavana Patel, Shannon Chiu, Melissa J. Armstrong JAMA Neurology.2022; 79(4): 331. CrossRef
Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population Cristina Simonet, Jonathan Bestwick, Mark Jitlal, Sheena Waters, Aaron Ben-Joseph, Charles R. Marshall, Ruth Dobson, Soha Marrium, John Robson, Benjamin M. Jacobs, Daniel Belete, Andrew J. Lees, Gavin Giovannoni, Jack Cuzick, Anette Schrag, Alastair J. No JAMA Neurology.2022; 79(4): 359. CrossRef
Auditory impairment in H‐ABC tubulinopathy Alejandra Lopez‐Juarez, Arturo Gonzalez‐Vega, Anke Kleinert‐Altamirano, Valeria Piazza, Angeles Garduno‐Robles, Milvia Alata, Carlos Villaseñor‐Mora, Jose R. Eguibar, Carmen Cortes, Luis Carlos Padierna, Victor H. Hernandez Journal of Comparative Neurology.2021; 529(5): 957. CrossRef
The Effect of Parkinson's Disease on Otoacoustic Emissions and Efferent Suppression of Transient Evoked Otoacoustic Emissions Evelien De Groote, Annelies Bockstael, Dick Botteldooren, Patrick Santens, Miet De Letter Journal of Speech, Language, and Hearing Research.2021; 64(4): 1354. CrossRef
Hearing Loss in Neurological Disorders Siyu Li, Cheng Cheng, Ling Lu, Xiaofeng Ma, Xiaoli Zhang, Ao Li, Jie Chen, Xiaoyun Qian, Xia Gao Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Age-Related Changes in the Cochlea and Vestibule: Shared Patterns and Processes Vasiliki Paplou, Nick M. A. Schubert, Sonja J. Pyott Frontiers in Neuroscience.2021;[Epub] CrossRef
Auditory Dysfunction in Parkinson's Disease Zahra Jafari, Bryan E. Kolb, Majid H. Mohajerani Movement Disorders.2020; 35(4): 537. CrossRef
Future Perspectives on the Relevance of Auditory Markers in Prodromal Parkinson's Disease Evelien De Groote, Kim De Keyser, Patrick Santens, Durk Talsma, Annelies Bockstael, Dick Botteldooren, Miet De Letter Frontiers in Neurology.2020;[Epub] CrossRef